ArticleMaterials today. Proceedings2022
Big data analytics for mask prominence in COVID pandemic.
Article in Materials today. Proceedings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 9 citations in OpenAlex.
- A Systematic Literature Review and Future Perspectives for Handling Big Data Analytics in COVID-19 Diagnosis.New generation computing · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corona Virus is spreading at an alarming rate in community causing respiratory diseases like SARS and MERS, which has laid down Government agencies and healthcare organizations to adopt and recommend various strategies in order to cease the spread of corona virus. Till the dawn of Vaccine, only available cost-effective preventive aid is the use of face mask. Since the outbreak of covid-19, demand for the face mask has been increased tremendously which has led to the shortage of face mask. Various masks are available in the market, but reuse and decontamination of reusable face mask has become the topic of concern. Commonly available masks in market are N-95, Medical/Surgical Mask and cloth masks. N-95 and Respirators should be reserved for frontline primary Healthcare professionals which are involved in High-risk aerosol generating procedures, while Surgical and medical mask should be used by secondary healthcare professionals and cloth masks by General public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.